Biotech Archives - Page 118 of 795

1 minute read

Bionano Publishes Interim Readout From Second Phase Of Clinical Trial Analyzing Optical Genome Mapping As Standard Of Care For Prenatal Testing

January 24, 9:13 AM

Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome mapping (OGM) that is designed to measure the workflow's accuracy and clinical

BNGO

2 minute read

Iridex Announces First Patient Enrollment In MicroPulse TLT Clinical Study Conducted In Collaboration With Imperial College Healthcare NHS Trust

By Benzinga Newsdesk

January 24, 9:12 AM

Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the first patient enrollment in a collaborative medical research study and registry

IRIX

2 minute read

Twist Bioscience Expands Express Genes Rapid Synthesis Service

By Benzinga Newsdesk

January 24, 9:10 AM

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express Genes, a

TWST

2 minute read

ZyVersa Therapeutics Announces Peer-Reviewed Article Supporting The Therapeutic Potential Of Targeting ASC Specks During Progression Of Alzheimer’s Disease

By Benzinga Newsdesk

January 24, 9:02 AM

Research demonstrated that activation of the inflammasome/ASC speck pathway has a vital role in synaptic degeneration in Alzheimer's Disease (AD).ZyVersa is developing IC 100, a monoclonal antibody targeting inflammasome

ZVSA

2 minute read

What’s Going On Johnson & Johnson Stock Today?

By Vandana Singh

January 24, 8:54 AM

JNJ reports strong earnings, beats expectations for Q4 of 2023, with increased sales and successful acquisitions. Stock closes lower, settles talc litigation, and delays competitor's launch.

AMGN

2 minute read

Johnson & Johnson’s Settlement For Talc Cancer Lawsuits Reaches $700M Settlement With US States

By Vandana Singh

January 23, 2:18 PM

Johnson & Johnson settles state investigations for $700 million, addressing alleged talc product safety issues linked to cancer.

JNJ

1 minute read

Opioid Developer Ensysce Biosciences Stock Is Shooting Higher Today – Here’s Why

By Vandana Singh

January 23, 2:13 PM

Ensysce Biosciences breakthrough in opioid innovation! FDA grants PF614-MPAR BTD for enhanced pain relief with overdose protection. Learn more about this cutting-edge drug.

ENSC

2 minute read

What’s Going On With Danish Healthcare Firm Genmab Stock?

By Vandana Singh

January 23, 2:11 PM

Genmab's legal update on Darzalex: Arbitrator dismisses bid for milestone payments. Despite this, diverse revenue sources, including royalty agreements, contribute to strong growth.

GMAB

2 minute read

FDA Green Lights Cybin’s Psychedelic Clinical Study Assessing Generalized Anxiety

By Lara Goldstein

January 23, 1:15 PM

Cybin will advance the clinical development of the novel psychedelic molecule CYB004 for generalized anxiety treatment.

CYBN

4 minute read

Akouos, Inc., A Wholly Owned Subsidiary Of Eli Lilly Announces Phase 1/2 Clinical Trial Data For An Investigational Gene Therapy For Genetic Hearing Loss To Be Presented At The Association For Research In Otolaryngology 2024 MidWinter Meeting

By Benzinga Newsdesk

January 23, 1:01 PM

Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant, the first to receive gene therapy in the United States for a genetic form of

LLY